TriSalus Life Sciences (TLSI) Current Assets (2020 - 2026)

TriSalus Life Sciences (TLSI) has 7 years of Current Assets data on file, last reported at $68.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 171.51% year-over-year to $68.1 million; the trailing twelve-month figure through Mar 2026 stood at $68.1 million (up 171.51% YoY), and the FY2025 full-year result was $32.2 million, up 56.0% from the prior year.
• Current Assets for Q1 2026 stood at $68.1 million, up from $32.2 million in the prior quarter.
• Across five years, Current Assets topped out at $68.1 million in Q1 2026 and bottomed at $161454.0 in Q2 2023.
• The 5-year median for Current Assets is $20.9 million (2023), against an average of $20.6 million.
• The widest annual swing landed in 2022, when Current Assets plunged 80.26%; it then soared 17205.86% in 2024.
• A 5-year view of Current Assets shows it stood at $17.2 million in 2022, then gained by 21.19% to $20.9 million in 2023, then dropped by 0.93% to $20.7 million in 2024, then soared by 56.0% to $32.2 million in 2025, then jumped by 111.32% to $68.1 million in 2026.
• The last three Current Assets figures came in at $68.1 million (Q1 2026), $32.2 million (Q4 2025), and $33.3 million (Q3 2025), per Business Quant data.

Peer Comparison